Patient with polycythemia vera receiving radiation to spleen: a case report and review of the literature.

Authors

  • ปิยะ ประทีปะเสน พ.บ., ว.ว.(รังสีวิทยาทั่วไป), อ.ว.(รังสีวิทยา)

Abstract

Palliative treatment of splenomegaly from various malignant hematologic diseases using radiation has been accepted for a long time. Objective of splenic radiation is to relief clinical symptoms of splenomegaly and other clinical sequels of hypersplenism. Radiation to spleen gives good result with low toxicity. The most common side effects are thrombocytopenia and anemia which can not easily distinguish from underlying malignant hematologic diseases. This is a report case of a 55-year-old female with the diagnosis of polycythemia vera. The patient had huge splenomegaly with symptom of moderately severe abdominal distress. The patient was send to Radiation Therapy Department for splenic irradiation. Daily dose of 1.2 Gy for 5 fractions using right and left parallel oblique port was given to the patient causing minimal symptoms relieved. Thus, the daily dose was increased to 1.5 Gy for 5 more fractions. Second CT simulation was done after 13.5 Gy in 10 fractions. Anterior-posterior parallel opposed port with a daily dose of 2 Gy for 10 fractions was given to a shrinking spleen. The patient tolerated treatment very well and remained symptom-free at the end of treatment without any hematologic complication. Two and a half years follow-up showed no abdominal symptom nor hematologic sequelae. The literatures about splenic radiation are reviewed.

References

1. Nazmy MS, Radwan A, Mokhtar M. Palliative spleen irradiation: can we standardize its technique? J Egypt Natl Canc Inst. 2008; 20:31-5.

2. Iyer R, Jhingran A. Radiation injury: imaging findings in the chest, abdomen and pelvis after therapeutic radiation. Cancer Imaging. 2006; 6:S131-9.

3. Stevens M, Brown E, Zipursky A. The effect of abdominal radiation on spleen function: a study in children with Wilms' tumor. Pediatr Hematol Oncol. 1986; 3:69-72.

4. Aabo K, Walbom-Jorgensen S. Spleen irradiation in chronic lymphocytic leukemia (CLL): palliation in patients unfit for splenectomy. Am J Hematol. 1985; 19: 177-80.

5. Osorio JI, Watkins JM, Strange C, Jenrette JM 3rd. Radiation therapy for palliation of Eisenmenger's syndrome-associated painful splenomegaly. Radiat Med. 2008; 26:84-7.

6. Shrimali RK, Correa PD, O'Rourke N. Low-dose palliative splenic irradiation in haematolymphoid malignancy. J Med Imaging Radiat Oncol. 2008; 52:297-302.

7. Schratter-Sehn AU, Cerveny M, Simmel H, Schlögl E, Schratter A. Short-time splenic irradiation for splenomegaly. Onkologie. 2003; 26:21-4.

8. McFarland JT, Kuzma C, Millard FE, Johnstone PA. Palliative irradiation of the spleen. Am J Clin Oncol. 2003; 26: 178-83.

9. Elliott MA, Chen MG, Silverstein MN, Tefferi A. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia. Br J Haematol. 1998; 103:505-11.

10. Soldić Z, Murgić J, Jazvić M, Radić J, Bolanca A, Stancić V, et al. Splenic irradiation in hematologic malignancies and other hematologic disorders--single institution experience. Acta Clin Croat. 2011; 50:29-35.

Downloads

Published

2019-11-06

How to Cite

1.
ประทีปะเสน ป. Patient with polycythemia vera receiving radiation to spleen: a case report and review of the literature. J Thai Assn of Radiat Oncol [Internet]. 2019 Nov. 6 [cited 2024 May 3];20(1):22-6. Available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/224287

Issue

Section

Original articles